Skip to main content

Table 3 Parameters for survival

From: Concurrent chemoradiation of metastases with capecitabine and oxaliplatin and 3D-CRT in patients with oligometastatic colorectal cancer: results of a phase I study

 

Dosis 1

Dosis 2

∑

 

Survived

Lost to Follow up

Survived

Lost to Follow up

Survived

Lost to Follow up

1 year

6

0

3

0

9

0

3 years

3

0

0

3

3

3

  1. One year after initiation all patients were alive, three patients had died of tumor progression within the following three years.
Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us